INSIGHTS ON CLINICAL TRIAL PARTNERING
-
3 Reasons Sponsors Should Own The RTSM Vendor Relationship
Explore how direct management of study randomization and supply chains reduces communication delays, improves system design, and protects clinical data integrity from accidental unblinding.
-
Five Preventable Clinical Design Pitfalls And How To Avoid Them
While late-stage trial attrition is often attributed to inadequate safety or efficacy, the true failure may be insufficient upstream planning and/or misalignment between clinical and commercial goals.
-
Is Your Help Desk A Lifeline Or A Landline?
A help desk should accelerate trial success, not create delays. Discover how proactive support and modern tools turn help desks into strategic assets that improve efficiency and reduce risk.
-
Central eSource: Leveraging Site Technology
In this presentation, CRIO founder and co-CEO Raymond Nomizu delves into how sponsors can leverage the electronic source trend among sites through the use of Central eSource.
-
Scaling Outsourced Clinical Trial Services6/16/2026
Scaling outsourced clinical services increases operational pressure. Here’s where strain appears, how structure absorbs volume, and what sponsors should evaluate as programs expand.
-
Big Futures For Emerging Biopharma: Navigating Biotech Hurdles1/14/2026
Emerging biopharma drives agile, data-driven, patient-focused drug development. Discover how to overcome complexity, speed timelines, and thrive in a fast-changing healthcare landscape.
-
Tech Transfer Strategies For mAb Drug Products In Late-Phase Launch8/7/2025
Tech transfer is not just a process of replicating manufacturing steps; it is a complex, multidisciplinary effort that ensures process robustness, scalability, regulatory compliance, and supply chain readiness.
-
DCTs And Community-Based Research Execution And Compliance5/28/2025
The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.
-
Creating A New World In Clinical Trial Feasibility Utilizing Advanced Analytics11/26/2024
Citeline utilizes several data resources to enhance feasibility strategies and help clients drive patient engagement and recruitment.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.
-
Learn more about the Global ESG Program and how the continued development of sustainability initiatives contributes to positive impact on the environment and the communities in which we operate.
-
CNS drug development faces unique hurdles — from high placebo response to complex protocols and recruitment challenges. Discover strategies to streamline trials, optimize planning, and accelerate delivery of innovative therapies for patients with critical unmet needs.
-
Enable consistent protocol execution with standardized workflows for training, monitoring, documentation, inventory, and drug accountability.
-
Unlock an enhanced customer experience through digital transformation by applying real-time visibility into your supply chain using cross-functional workflows and data-driven insights.